Bimekizumab
Drug timelines are a Plus or Pro feature.
50 regulatory and trial events tracked for Bimekizumab, covering 2020-11-16 to 2026-08-21. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Test the Long-term Treatment of Bimekizumab in Study Participants With Moderate to Severe Hidradenitis Suppurativa [Phase 3]